跳至主要内容
临床试验/CTRI/2024/05/067368
CTRI/2024/05/067368尚未招募4 期

The effect of oral Tizanidine as premedication on postoperative pain after breast surgery - a prospective randomised double blind study.

Dr R Anuradha1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2024年6月15日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
86
试验地点
1
主要终点
Postoperative pain score and requirement of rescue analgesia.

研究概览

简要总结

Tizanidine is an alpha 2 agonist. It has analgesic and muscle relaxant properties. Post operative pain can cause adverse physiological effects including insufficient depth of breathing, failure to drain respiratory secretions and other pulmonary complications. This study will be done to evaluate the effect of Tizanidine on post operative pain after breast surgeries. It is a prospective double blind randomised control study. Post operative pain and requirement of rescue analgesic will be monitored.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
Female

入选标准

  • Patients of ASA grade 1 and 2 Patients scheduled for carcinoma breast surgeries.

排除标准

  • History of moderate to severe congenital heart disease, neurological disorder, hepatic or renal diseases Patients with hiatal hernia, major abdominal or thoracic surgery Patients with history of alpha 2 agonist in last few days to months.

结局指标

主要结局

Postoperative pain score and requirement of rescue analgesia.

时间窗: 0 minute, 30 minutes, 60 minutes, 90 minutes, 2 hours, 3 hours, 4 hours,6 hours,12 hours, 24 hours.

次要结局

  • Length of PACU stay, patient satisfaction and any adverse events(24 hours)

研究者

发起方
Dr R Anuradha
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr R Anuradha

Indira Gandhi Institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验